活动性肺结核合并哮喘患者使用激素的临床研究

Study on hormone in treatment for patients with campaign tuberculosis combined asthma

目的探讨活动性肺结核合并哮喘患者激素的使用价值。方法两组患者均符合肺结核合并哮喘的诊断标准。治疗组45例采用2H3R3Z3E3/4H3R3+BDP或琥珀酸氢化可的松+氨茶碱、β2-受体激动剂;对照组37例采用2H3R3Z3E3/4H3R3+氨茶碱、β2-受体激动剂。比较两组抗痨效果及哮喘病的复发率。结果两组2、5、6个月的痰检显示无显著意义;完成治疗后,治疗组复发率低,对照组复发率高,两者有显著意义。结论活动性肺结核合并哮喘的患者在抗痨治疗的同时,吸入糖皮质激素治疗可以减少复发率,安全、有效。

Objective To study the value of using hormone on the patients who have campaign tuberculosis combined asthma.Methods Two groups of patients were both according with the diagnosis standard of tuberculosis combined asthma.The treatment group（45 cases）were adoped 2H3R3Z3E3/4H3R3＋BDP or Hydrocortisone Succinate＋Aminophylline,[32-AR agonist.The control group （37 cases）were adoped 2 H3R3Z3E3/4H3R3＋Aminophylline,β2-AR agonist.The antituberculosis effect of two groups and asthma recurring rate were compared.Results The 2th,5th and 6th month sputum examination of two groups show without notable significance,after being treated, the recurring rate was lower in the treatment group,and higher in the control group,the difference of the two groups was significance. Conclusion The recurring rate can decrease if the patients with campaign tuberculosis combined asthma take antituberculosis treatment and at the same time suck in glucocorticoids,it is safe and effective.